MedPage Today on MSN
Precision Therapy for Genetic Dilated Cardiomyopathy a Growing Possibility
Danicamtiv is an investigational selective agonist of cardiac myosin, intended to help myocyte contraction by enhancing ...
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J., September 29, 2025--Kardigan, a heart health company modernizing ...
Panelists discuss how heart failure creates a massive economic burden of approximately $30 billion annually (expected to ...
A shutdown could have impacts on Coloradans in large and small ways across the state, especially if it were not quickly resolved ...
Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...
Aficamten is also currently being evaluated in ACACIA-HCM, a Phase 3 clinical trial of aficamten in patients with non-obstructive HCM; CEDAR-HCM, a clinical trial of aficamten in a pediatric ...
CorWave presented positive interim results from its first-in-human study of the CorWave Left Ventricular Assisting System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback